Article Text

Download PDFPDF
Treatment options in bulky stage IB cervical carcinoma
  1. J. Petsuksiri*,
  2. Y. Chansilpa*,
  3. S. Therasakvichya,
  4. N. Suntornpong*,
  5. K. Thephamongkhol*,
  6. P. Dankulchai*,
  7. P. Mahasitthiwat*,
  8. N. Ieumwananonthachai*,
  9. V. Veerasarn*,
  10. S. Sangruchi* and
  11. P. Pattaranutaporn*
  1. * Division of Radiation Therapy, Department of Radiology and
  2. Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  1. Address correspondence and reprint requests to: Janjira Petsuksiri, MD, Division of Radiation Therapy, Department of Radiology, Faculty of Medicine Siriraj Hospital, 2 Prannok Road, Bangkoknoi, Bangkok 10700, Thailand. Email: janjira102{at}


Cervical cancer is the most common female cancer in the developing countries. Treatments of bulky stage IB cervical cancer have been challenged as the local control is relatively poor compared to smaller stage I disease, whether treated by radical surgery or irradiation. The treatment options are definitive concurrent chemoradiation therapy or radical surgery with or without neoadjuvant or adjuvant therapy. The treatment decision is based on the patients' status and preferences, tumor characteristics, and experiences of clinician. This study will review and compare the treatment modalities and rationales of a combination of treatment including surgery, radiation therapy, and chemotherapy for bulky stage IB cervical carcinoma.

  • bulky stage IB
  • cervical carcinoma
  • cervix

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.